The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 13, 2026

Filed:

Sep. 09, 2022
Applicants:

Onechain Immunotherapeutics, S.l, Barcelona, ES;

Fundació Institut D'investigació En Ciències DE LA Salut Germans Trias L Pujol (Igtp), Badalona, ES;

Universitat DE Barcelona, Barcelona, ES;

Institució Catalana DE Recerca I Estudis Avançats (Icrea), Barcelona, ES;

Fundació Institut DE Recerca Contra LA Leucèmia Josep Carreras, Badalona, ES;

Inventors:

Pablo Menéndez Buján, Badalona, Barcelona, ES;

Talía Velasco Hernández, Badalona, Barcelona, ES;

Samanta Romina Zanetti, Badalona, Barcelona, ES;

Pablo Engel Rocamora, Barcelona, ES;

Diego Sánchez Martínez, Badalona, Barcelona, ES;

Francisco Gutierrez Agüera, Badalona, Barcelona, ES;

Adrián Fernández Martín, Badalona, Barcelona, ES;

Victor Manuel Díaz Cortés, Barcelona, ES;

Assignee:

UNIVERSITAT DE BARCELONA, BARCELONA, ES;

Primary Examiner:
Int. Cl.
CPC ...
U.S. Cl.
CPC ...
C07K 16/2896 ; A61P 35/00 ; A61K 2239/48 ; A61K 2239/31 ; A61K 2239/38 ; A61K 40/4212 ; A61K 40/31 ; A61K 40/11 ; C07K 2317/622 ; C07K 2319/02 ; C07K 2319/03 ; C12N 5/0636 ;

Find Patent Forward Citations

Quick Actions:

Menéndez Buján, Pablo. (2026). Cd22 targeting-moiety for the treatment of b-cell acute lymphoblastic leukemia (b-all) (U.S. Patent No. 12522666). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12522666

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…